New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2013
11:55 EDTMLNX, ISIS, INVN, TPX, CRUSStocks with decreasing implied volatility; MLNX ISIS INVN TPX CRUS
Stocks with decreasing implied volatility; MLNX ISIS INVN TPX CRUS
News For MLNX;ISIS;INVN;TPX;CRUS From The Last 14 Days
Check below for free stories on MLNX;ISIS;INVN;TPX;CRUS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 25, 2014
08:47 EDTMLNXMellanox points to bigger than expected Grantley ramp, says Janney Capital
Subscribe for More Information
July 24, 2014
16:44 EDTTPXTempur Sealy sees 2014 adjusted EPS $2.60-$2.85, consensus $2.78
Sees 2014 revenue $2.925B-$2.975B, consensus $2.89B.
16:43 EDTTPXTempur Sealy reports Q2 adjusted EPS 39c, consensus 41c
Subscribe for More Information
16:27 EDTMLNXMellanox sees Q3 revenue $114M-$118M, consensus $113.78M
Sees Q3 Non-GAAP gross margins of 68%-69%.
16:27 EDTMLNXMellanox reports Q2 EPS 15c, consensus 10c
Reports Q2 revenue $102.6M, consensus $102.6M.
10:26 EDTCRUSOptions with decreasing implied volatility
Subscribe for More Information
July 23, 2014
18:34 EDTCRUSOn The Fly: After Hours Movers
UP AFTER EARNINGS: Fortinet (FTNT), up 7.8%... Hanesbrands (HBI), up 5.4%... 8x8 (EGHT), up 5.1%... Infinera (INFN), up 4.9%... Facebook (FB), reverses and is now trading up 5.1% following second quarter earnings conference call. NOTABLE: Twitter (TWTR), up 1.7%, LinkedIn (LNKD), up marginally, and Yelp (YELP), up 1.6% after Facebook reports second quarter results. ALSO HIGHER: Spectranetics (SPNC), up 7.1% after receiving FDA clearance for atherectomy products, Turbo-Tandem and Turbo Elite... Ariad Pharmaceuticals (ARIA), up 7.1%... Jamba (JMBA), up 3.8% after Engaged Capital reports stake in the company and announced that they had discussions with management. DOWN AFTER EARNINGS: AT&T (T), down 1.2%... Angie's List (ANGI), down 16.4%... Tripadvisor (TRIP), down 11.5%... Orchids Paper (TIS), down 7.4%... Cirrus Logic (CRUS), down 6.6%... Cliffs Natural (CLF), down 1.2%... Teradyne (TER), down 4%. ALSO LOWER: Kandi Technologies (KNDI), down 3.8% after being mentioned negatively in a Seeking Alpha blog post.
16:03 EDTCRUSCirrus Logic sees Q2 revenue $175M-$195M, consensus $185.86M
Sees Q2 gross margin 47%-49%. The company said, “We are pleased with our Q1 financial results as we experienced strong demand for our custom and general market portable audio products across our customer base. With a robust pipeline of innovative products and the pending acquisition of Wolfson, we are strengthening the company’s position as a market leader in audio with a comprehensive product portfolio, differentiated software capabilities and a top-tier customer base.” The company expects to close its Wolfson Microelectronics acquisition in the September quarter.
16:01 EDTCRUSCirrus Logic reports Q1 adjusted EPS 37c, consensus 30c
Reports Q1 revenue $152.6M, consensus $148.03M. Reports Q1 gross margin of 49%.
10:49 EDTINVNInvenSense likely won part of motion gyro sensor in iPhone 6, says Pacific Crest
Subscribe for More Information
July 22, 2014
16:35 EDTMLNXMellanox initiated with an Outperform at Imperial Capital
Subscribe for More Information
July 17, 2014
07:10 EDTISISIsis Pharmaceuticals begins Phase 2 study of candidate for high lipoprotein(a)
Subscribe for More Information
July 16, 2014
11:17 EDTINVNRosenblatt believes InvenSense won OIS for Galaxy Note 4
Subscribe for More Information
10:00 EDTMLNXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:23 EDTMLNXOn The Fly: Pre-market Movers
HIGHER: Time Warner (TWX), up 15% after company confirmed that it rejected an $80B takeover offer from 21st Century Fox (FOX, FOXA), as had been reported earlier this morning... Apple (AAPL), up 2% after announcing an enterprise mobile partnership with IBM (IBM), which is also up 2%... International Game (IGT), up 9.5% after agreeing to be acquired by GTECH for $4.7B in cash and stock... FireEye (FEYE), up 5% after shares upgraded at Goldman... Precision Drilling (PDS), up 4% after announcing strategic agreement with Schlumberger (SLB), upgraded at Deutsche Bank... Mellanox (MLNX), up 4.7% following upgrade at Jefferies. UP AFTER EARNINGS: Intel (INTC), up 5.4%... HCA Holdings (HCA), up 6%... Textron (TXT), up 3.2%... Abbott (ABT), up 1%. DOWN AFTER EARNINGS: PNC Financial (PNC), down 2.5%... MGIC Investment (MTG), down 3.6%. LOWER: Yahoo (YHOO), down 3% after downgraded at CRT Capital following second quarter earnings report... Ares Capital (ARCC), down 2.5% after filing to sell 11.85M shares of common stock... Nationstar (NSM), down 2.4% after downgraded at Wells Fargo... Walter Investment (WAC), which was also downgraded at Wells Fargo, down 1.6%.
08:00 EDTINVNInvenSense Orbotech look good into Q2 results, says Oppenheimer
Subscribe for More Information
07:39 EDTMLNXIntel comments bode well for Mellanox, says Macquarie
Intel (INTC) said on its earnings call that the Haswell-EP Xeon E5 high-performance CPU built on the Grantley platform is already being shipped in pre-production quantities and is on track for a CYQ3 launch. Macquarie said Intel's commentary is a positive for the HPC market and Mellanox (MLNX) should see corresponding demand. Shares are Outperform rated with a $52 price target.
07:30 EDTMLNXMellanox upgraded to Buy from Hold at Jefferies
Subscribe for More Information
07:14 EDTISISIsis Pharmaceuticals earns $1M milestone payment from GlaxoSmithKline
Isis Pharmaceuticals (ISIS) has earned a $1M milestone payment from GlaxoSmithKline (GSK) related to the advancement of the Phase 2/3 study of ISIS-TTRRx in patients with familial amyloid polyneuropathy. ISIS-TTRRx is an antisense drug in development with GSK for the treatment of transthyretin amyloidosis, a severe and rare genetic disease characterized by progressive dysfunction of peripheral nerve and/or heart tissues. Including this milestone payment, Isis has generated $27M in upfront and milestone payments for advancing ISIS-TTRRx. If GSK elects to exercise its option to exclusively license the ISIS-TTRRx program, Isis is eligible to receive a license fee, regulatory and sales milestone payments and double-digit royalties on sales of ISIS-TTRRx.
06:07 EDTMLNXMellanox upgraded to Buy from Hold at Jefferies
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use